In a groundbreaking study presented at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology, researchers revealed that embryos from women with polycystic ovary syndrome (PCOS) carry a unique “epigenetic memory.” This discovery could shed light on the reasons why PCOS often runs in families.
Polycystic ovary syndrome is a common hormonal disorder affecting about 1 in 10 women of reproductive age worldwide. Characterized by irregular menstrual cycles, high androgen levels, and ovarian cysts, PCOS is a leading cause of infertility. Despite its prevalence, the precise causes and hereditary nature of the condition remain a mystery.
Led by Dr. Qianshu Zhu, the study analyzed oocytes (egg cells) and embryos from 133 women with PCOS and 95 non-PCOS infertile women undergoing fertility treatments. The team employed advanced sequencing techniques to investigate gene activity and epigenetic changes—chemical markers that regulate gene function without altering DNA.
The findings showed significant disruptions in the embryos of women with PCOS, affecting key genes involved in early development and metabolic processes. Notably, irregular patterns of histone marks, which play a crucial role in controlling gene expression, were identified. One particular marker, H3K27me3, revealed concerning abnormalities that began even before embryo implantation, indicating an epigenetic signal passed from mother to embryo.
Dr. Zhu expressed excitement over the findings, stating, “We were surprised to find that H3K27me3, known for its role in cancer biology, could also influence PCOS.” He emphasized that this opens new possibilities for embryo assessment and potential interventions.
The study also indicates that epigenetic profiling could one day complement existing diagnosis methods for PCOS, allowing for earlier risk assessments for children conceived by affected mothers. Furthermore, in assisted reproductive technologies like IVF, these histone patterns might serve as biomarkers for selecting the healthiest embryos, potentially improving fertility treatment outcomes.
This research marks an important step toward understanding the molecular roots of PCOS and may lead to future prevention strategies. As Dr. Zhu stated, “If we confirm that altering these histone marks changes PCOS traits in the next generation, we’ll have a powerful target for prevention.”
-Rashmi Kumari




